标题
Nanoparticle approaches to combating drug resistance
作者
关键词
-
出版物
Future Medicinal Chemistry
Volume 7, Issue 12, Pages 1503-1510
出版商
Future Science, LTD
发表日期
2015-08-27
DOI
10.4155/fmc.15.82
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer
- (2013) Fan Bai et al. BIOMATERIALS
- The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer
- (2013) Jia Zhou et al. BIOMATERIALS
- Targeting Mitochondrial DNA with a Platinum-Based Anticancer Agent
- (2013) Simon P. Wisnovsky et al. CHEMISTRY & BIOLOGY
- Reversal of Multidrug Resistance by Mitochondrial Targeted Self-Assembled Nanocarrier Based on Stearylamine
- (2013) Zhiwen Zhang et al. MOLECULAR PHARMACEUTICS
- Anti-P-glycoprotein conjugated nanoparticles for targeting drug delivery in cancer treatment
- (2011) Pantiwa Iangcharoen et al. ARCHIVES OF PHARMACAL RESEARCH
- Redox-Responsive Nanoparticles from the Single Disulfide Bond-Bridged Block Copolymer as Drug Carriers for Overcoming Multidrug Resistance in Cancer Cells
- (2011) Yu-Cai Wang et al. BIOCONJUGATE CHEMISTRY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Nanomedicine for targeted cancer therapy: Towards the overcoming of drug resistance
- (2011) Alina Shapira et al. DRUG RESISTANCE UPDATES
- Enhanced Chemotherapy of Cancer Using pH-Sensitive Mesoporous Silica Nanoparticles to Antagonize P-Glycoprotein-Mediated Drug Resistance
- (2011) I.-P. Huang et al. MOLECULAR CANCER THERAPEUTICS
- Liposome-Encapsulated Doxorubicin Reverses Drug Resistance by Inhibiting P-Glycoprotein in Human Cancer Cells
- (2011) Chiara Riganti et al. MOLECULAR PHARMACEUTICS
- Poly(l-lactide)-Vitamin E TPGS Nanoparticles Enhanced the Cytotoxicity of Doxorubicin in Drug-Resistant MCF-7 Breast Cancer Cells
- (2010) Po-Yu Li et al. BIOMACROMOLECULES
- F3-Targeted Cisplatin-Hydrogel Nanoparticles as an Effective Therapeutic That Targets Both Murine and Human Ovarian Tumor Endothelial Cells In vivo
- (2010) I. Winer et al. CANCER RESEARCH
- Nanomedicinal strategies to treat multidrug-resistant tumors: current progress
- (2010) Xiaowei Dong et al. Nanomedicine
- The therapeutic response to multifunctional polymeric nano-conjugates in the targeted cellular and subcellular delivery of doxorubicin
- (2009) Xiao-Bing Xiong et al. BIOMATERIALS
- Doxorubicin and Paclitaxel-Loaded Lipid-Based Nanoparticles Overcome Multidrug Resistance by Inhibiting P-Glycoprotein and Depleting ATP
- (2009) X. Dong et al. CANCER RESEARCH
- Active targeting schemes for nanoparticle systems in cancer therapeutics
- (2008) James D. Byrne et al. ADVANCED DRUG DELIVERY REVIEWS
- Therapeutic Nanoparticles for Drug Delivery in Cancer
- (2008) K. Cho et al. CLINICAL CANCER RESEARCH
- In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells
- (2008) Ken-ichi Ogawara et al. JOURNAL OF CONTROLLED RELEASE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started